Kangmei Pharma | 600518 - Sales Revenues

Stock Price
1.78
Daily Change
-0.01 -0.56%
Monthly
-5.32%
Yearly
-11.00%
Q2 Forecast
1.71

Kangmei Pharma reported CNY1.37B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Genomma Lab Internacional MXN 4.02B 620M Dec/2025
Hypermarcas BRL 2.24B 9.82M Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Jiangsu Hengrui CNY 8.44B 1.01B Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sh Fosun Pharma CNY 9.81B 2.35B Mar/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Wuxi Apptec CNY 12.6B 88.06M Dec/2026
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025